Abdominal Aortic Junction Tourniquet (AAJT-S) for Non-compressible Torso Haemorrhage
Launched by MEDICAL UNIVERSITY OF GRAZ · Oct 1, 2024
Trial Information
Current as of July 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new method called the Abdominal Aortic Junction Tourniquet (AAJT-S), which is designed to help patients who are experiencing severe bleeding from injuries in their lower body. The goal is to see if this technique can effectively control bleeding in emergency situations, both at the hospital and before patients arrive at the hospital. The trial is currently looking for participants who are 18 years or older and have life-threatening injuries that might benefit from this treatment.
To be included in the study, participants need to show signs of serious bleeding or low blood flow due to trauma in the lower part of their body. However, those who might have other sources of bleeding above the belly button, are pregnant, or have a specific type of blood vessel problem (an abdominal aortic aneurysm) cannot join. If eligible, participants will receive the AAJT-S treatment and be monitored closely by healthcare professionals throughout the process. This trial aims to improve emergency care for patients with critical injuries and ultimately save lives.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • aged, or believed to be aged, 18 years or above,
- • confirmed or suspected life-threatening lower body trauma (i.e. signs of inadequate perfusion of tissues, tachycardia, hypotension, suspected blood loss)
- • is thought to benefit from trauma resuscitation with AAJT-S or REBOA zone III
- Exclusion Criteria:
- • suspected additional bleeding source proximal to the umbilicus, or
- • known or suspected pregnancy at presentation, or
- • known abdominal aortic aneurysm
About Medical University Of Graz
The Medical University of Graz, a leading institution in Austria, is dedicated to advancing medical knowledge and improving patient care through innovative research and clinical trials. Renowned for its interdisciplinary approach, the university collaborates with various healthcare professionals and researchers to explore cutting-edge therapies and treatments. With a commitment to ethical standards and patient safety, the Medical University of Graz actively contributes to the global medical community by facilitating rigorous clinical trials that aim to translate scientific discoveries into practical applications for improved health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Graz, Styria, Austria
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported